Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
DHR
Eligibility
Inclusion criteria
Inclusion criteria: Women with proved histopathological carcinoma breast willing to participate in study
Exclusion criteria
Exclusion criteria: Patients already on chemotherapy/Radiotherapy Pregnancy Systemic inflammatory/Autoimmune disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study is expected to provide region-specific evidence regarding the presence and role of HPV in breast cancer, which may contribute to understanding breast carcinogenesis and future preventive strategies.Timepoint: The study is expected to provide region-specific evidence regarding the presence and role of HPV in breast cancer, which may contribute to understanding breast carcinogenesis and future preventive strategies. | — |
Secondary
| Measure | Time frame |
|---|---|
| If association is proven then role of vaccination against human papilloma virus in decreasing the incidence of carcinoma breast can be studiedTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr Vikas Goyal
Government Medical College, Patiala
Outcome results
None listed